Terminated OBSERVATIONAL NCT04246892

Impact of Alarm Reduction on Delirium in ICU (ALADIN)

Sponsor: Central Hospital, Nancy, France

Conditions Delirium

Updated 7 times since 2020 Last updated: Aug 29, 2023 Started: Feb 3, 2020 Primary completion: Feb 23, 2023 Completion: Feb 23, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

technical problem, no change of the monitors in the ICU ward

Other terminated trials from Central Hospital, Nancy, France

See all terminations from Central Hospital, Nancy, France

Other Delirium trials with similar outcome

Browse all Delirium trials

Listed as NCT04246892, this observational or N/A phase trial focuses on Delirium and remains terminated or withdrawn. Sponsored by Central Hospital, Nancy, France, it has been updated 7 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Sep 2023 — Jul 2024 [monthly]

Terminated

Status: Suspended → Terminated
Mar 2023 — Sep 2023 [monthly]

Suspended

Status: Recruiting → Suspended
May 2021 — Mar 2023 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Jan 2021 — May 2021 [monthly]

Not Yet Recruiting
Feb 2020 — Jan 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Central Hospital, Nancy, France

Data source: Central Hospital, Nancy, France

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nancy, France